Very low density lipoproteins provide a vector for secretion of paraoxonase-1 from cells

被引:54
作者
Deakin, S [1 ]
Moren, X [1 ]
James, RW [1 ]
机构
[1] Univ Hosp Geneva, Clin Diabet Unit, Div Endocrinol Diabetol & Nutr, Fac Med, CH-1211 Geneva, Switzerland
关键词
lipoproteins; atherosclerosis; oxidative stress;
D O I
10.1016/j.atherosclerosis.2004.08.039
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Paraoxonase-1 (PON1) 'requires a suitable acceptor complex for its secretion from producing cells. The serum lipoprotein, high-density lipoprotein (HDL) has been shown to accomplish this function, whereas low-density lipoproteins are ineffective. The present study examined the influence of the third serum lipoprotein subclass, very low density lipoproteins (VLDL), on PON1 secretion. VLDL were shown to promote secretion of PON1 from a transfected Chinese hamster ovary model and from transfected hepatocytes in a high-affinity, saturable manner. The effects of HDL and VLDL were not additive, suggesting that they may employ a common secretion pathway. VLDL was able to stabilise secreted PONI enzyme activity, but less effectively than stabilisation by HDL. Following co-incubation of VLDL and HDL, the majority of PON1 accumulated in HDL even if HDL was added after initial association of the enzyme with VLDL. VLDL to HDL transfer of PONI was rapid and did not require lipolysis of VLDL. Low levels of active PONI were associated with VLDL in human serum, and VLDL-associated enzyme activity was proportional to serum triglyceride concentrations. Serum triglycerides were positively associated with whole serum PONI mass but negatively associated with specific activity. PON1-entiched VLDL was more resistant to oxidation in vitro. The present study suggests that the triglyceride transport vector, VLDL, can modulate PONI metabolism and activity. This is due, in part, to an influence of the lipoprotein on PON1 secretion. PON1 was associated with VLDL in human serum, where triglycerides correlated independently with variations in serum mass and activity of the enzyme. VLDL-associated PONI exerted an anti-oxidative effect, which may be of physiological benetit. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:17 / 25
页数:9
相关论文
共 24 条
[1]
IDENTIFICATION OF A DISTINCT HUMAN HIGH-DENSITY-LIPOPROTEIN SUBSPECIES DEFINED BY A LIPOPROTEIN-ASSOCIATED PROTEIN, K-45 - IDENTITY OF K-45 WITH PARAOXONASE [J].
BLATTER, MC ;
JAMES, RW ;
MESSMER, S ;
BARJA, F ;
POMETTA, D .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1993, 211 (03) :871-879
[2]
Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation [J].
Boemi, M ;
Leviev, I ;
Sirolla, C ;
Pieri, C ;
Marra, M ;
James, RW .
ATHEROSCLEROSIS, 2001, 155 (01) :229-235
[3]
Boisfer E, 2002, J LIPID RES, V43, P732
[4]
Cholesteryl ester hydroperoxide lability is a key feature of the oxidative susceptibility of small, dense LDL [J].
Chancharme, L ;
Thérond, P ;
Nigon, F ;
Lepage, S ;
Couturier, M ;
Chapman, MJ .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) :810-820
[5]
Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism [J].
Deakin, S ;
Leviev, I ;
Gomaraschi, M ;
Calabresi, L ;
Franceschini, G ;
James, RW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (06) :4301-4308
[6]
CONTINUOUS MONITORING OF INVITRO OXIDATION OF HUMAN LOW-DENSITY LIPOPROTEIN [J].
ESTERBAUER, H ;
STRIEGL, G ;
PUHL, H ;
ROTHENEDER, M .
FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 6 (01) :67-75
[7]
Overexpression of SR-BI by adenoviral vector reverses the fibrate-induced hypercholesterolemia of apolipoprotein E-deficient mice [J].
Fu, T ;
Kozarsky, KF ;
Borensztajn, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (52) :52559-52563
[8]
QUANTIFICATION OF HUMAN SERUM PARAOXONASE BY ENZYME-LINKED IMMUNOASSAY - POPULATION DIFFERENCES IN PROTEIN CONCENTRATIONS [J].
GARIN, MCB ;
ABBOTT, C ;
MESSMER, S ;
MACKNESS, M ;
DURRINGTON, P ;
POMETTA, D ;
JAMES, RW .
BIOCHEMICAL JOURNAL, 1994, 304 :549-554
[9]
DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM [J].
HAVEL, RJ ;
EDER, HA ;
BRAGDON, JH .
JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (09) :1345-1353
[10]
Iverius P H, 1986, Methods Enzymol, V129, P691